Skip to main content

Month: January 2022

HCI Group Declares Q1 2022 Quarterly Cash Dividend

TAMPA, Fla., Jan. 21, 2022 (GLOBE NEWSWIRE) — The board of directors of HCI Group, Inc. (NYSE:HCI), a holding company with operations in homeowners insurance, information technology services, real estate, and reinsurance, has declared a regular quarterly cash dividend in the amount of 40 cents per common share for the first quarter of 2022. The dividend will be paid March 18, 2022 to shareholders of record at the close of business February 18, 2022. About HCI Group, Inc.HCI Group, Inc. owns subsidiaries engaged in diverse, yet complementary business activities, including homeowners insurance, reinsurance, real estate and information technology services. HCI’s leading insurance operation, TypTap Insurance Company, is a rapidly growing, technology-driven insurance company that is expanding nationwide to provide homeowners and flood...

Continue reading

ST. JAMES GOLD CORP. (TSX-V: LORD) STRENGTHENS MANAGEMENT TEAM WITH APPOINTMENT OF SEAN TUFFORD AS DIRECTOR OF BUSINESS DEVELOPMENT

Vancouver, British Columbia, Jan. 21, 2022 (GLOBE NEWSWIRE) — St. James Gold Corp. (the “Company”) (TSXV: LORD) (OTCQB: LRDJF) (FSE: BVU3) is pleased to announce that Sean Tufford has joined the company as the Director of Business Development. This appointment is a crucial step for the leadership and the continued growth of the Company. Mr. Tufford of Halifax, Nova Scotia, has many years of experience in the investor relations and capital markets realm with strong personal connections to the international financial community. He has previously assisted several junior and development staged mineral resource companies in Canada, USA, and Mexico, including Canadian Metals, GoGold Resources, Brigus Gold, and he can call upon his team and wealth of experience in marketing, strategic partnerships, business development, raising capital,...

Continue reading

Iris Energy Executes Transformational 600MW Connection Agreement With AEP Texas, Increasing Power Capacity to 765MW (~22 EH/s¹). US$19m Security Deposit and Connection Fee Paid, Procurement and Construction Activities Underway.

Highlights600MW binding connection agreement executed with AEP Texas and $19m security deposit and connection fee paid Power capacity expected to increase from 165MW (4.6 EH/s) to 765MW (~22 EH/s1)15.2 EH/s (~530MW) of miners previously secured; and ~7 EH/s1 (~235MW) of potential additional capacity~22 EH/s1 would represent >10%2 of the total global network hashrate if operating today >300 acre freehold site (100% owned), with direct grid access located in the renewables heavy Panhandle region of Texas, USA Electrical connection expected to be completed during Q1 2023 15.2 EH/s execution plan now clear4.6 EH/s (165MW) – operating and under construction (BC, Canada) 10.6 EH/s (365MW) – procurement and construction activities underway (Texas)3.0 EH/s (100MW) targeted for 20223 7.6 EH/s (265MW) targeted for 2023SYDNEY,...

Continue reading

Proposals by the Nomination Board to the Annual General Meeting 2022 of Suominen

Aaron BarsnessAaron BarsnessSuominen Corporation’s stock exchange release on January 21, 2022 at 2:00 p.m. EET Proposal on the number of the members, on the composition, and on the Chair of the Board of Directors The Nomination Board of Suominen Corporation’s shareholders proposes to the Annual General Meeting that the number of Board members remains unchanged and would be six (6). The Nomination Board proposes to the Annual General Meeting that Andreas Ahlström, Björn Borgman, Jaakko Eskola, Nina Linander and Laura Raitio would be re-elected as members of Suominen Corporation’s Board of Directors. Out of the current Board members, Sari Pajari-Sederholm has informed that she is not available as a candidate for the Board of Directors. In addition, the Nomination Board proposes that Aaron Barsness would be elected...

Continue reading

Orchard Therapeutics Announces Publication in The Lancet of Long-term Clinical Outcomes with Libmeldy for the Treatment of Children with Early-onset MLD

Administration of one-time hematopoietic stem cell (HSC) gene therapy resulted in sustained, clinically meaningful benefits by preserving cognitive function and motor development in most patients 90% overall survival with up to 7.5 years of follow-up (median 3.2 years) in 29 patients BOSTON and LONDON, Jan. 21, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced the publication in The Lancet of long-term clinical outcomes evaluating the safety and efficacy of Libmeldy® (atidarsagene autotemcel) for the treatment of early-onset metachromatic leukodystrophy (MLD). Libmeldy is the only approved one-time gene therapy intended to correct the underlying cause of MLD for eligible patients in the European Union, UK, Iceland, Liechtenstein and Norway. Also known as OTL-200, it is an...

Continue reading

Iveda Launches UVC Germicidal Irradiation Solution to Combat COVID-19 Widespread

IvedaIveda Smart UVCMESA, Ariz., Jan. 21, 2022 (GLOBE NEWSWIRE) — Iveda (OTCQB: IVDA), the worldwide provider of IvedaAI™ intelligent video search technology, Sentir® video surveillance products, IvedaPinpoint™ and IvedaHome™ IoT (Internet of Things) platforms with smart devices, today announced the launch of its commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI) product. This product is the newest addition to Iveda’s smart city portfolio. “With the prevalence of the COVID-19 virus in our lives and its continuous mutation, we may have to assume that it’s not going away,” said David Ly, CEO of Iveda. “Common hygiene, social distancing and masking may not be enough to minimize the spread of the virus. As such, we offer a sensible solution to potentially irradicate all kinds of bacteria and viruses,...

Continue reading

The Scotts Miracle-Gro Company Announces Expiration and Results of Exchange Offer for 4.375% Senior Notes due 2032

MARYSVILLE, Ohio, Jan. 21, 2022 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG) today announced the expiration and results of its previously announced registered exchange offer to exchange any and all of its $400,000,000 aggregate principal amount of 4.375% Senior Notes due 2032, which were issued in a private placement on August 13, 2021 (the “Original Notes”), for an equal principal amount of its 4.375% Senior Notes due 2032, which have been registered under the Securities Act of 1933, as amended (the “Exchange Notes”). The exchange offer expired at 11:59 p.m., New York City time, on January 10, 2022. As of that time, $400,000,000 aggregate principal amount, or 100.0%, of the Original Notes had been validly tendered for exchange and not validly withdrawn. All of the Original Notes validly tendered and not validly...

Continue reading

Mesa Air Group Reports December 2021 Operating Performance

PHOENIX, Jan. 21, 2022 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) today reported Mesa Airlines’ operating performance for December 2021. Mesa Airlines reported 26,920 block hours in December 2021, a 3.8 percent increase from December 2020. Covid-19 and its impact on employee attendance was a primary factor behind Mesa’s controllable completion factor of 93.05 percent and 97.89 percent for its American and United operations, respectively. Operating statistics for December 2021 and fiscal year 2021 YTD are included in the table below.  Dec-21 Dec-20 % Change YTD FY2022 YTD FY2021 % ChangeBlock Hours            American 10,470   12,400   -15.6 % 33,129   31,368   5.6 %United 16,221   13,316   21.8 % 52,294   37,389   39.9 %DHL 229   217   5.3 % 655   490   33.7 %Total 26,920   25,933   3.8 % 86,079   69,247   24.3 %               Dec-21 Dec-20 %...

Continue reading

William “Bill” Conkling to assume the role of Chief Executive Officer as of February 1, 2022

NEWARK, N.J., Jan. 21, 2022 (GLOBE NEWSWIRE) — Rafael Holdings, Inc., (NYSE: RFL), a company focused on discovering and developing novel cancer and immune metabolism therapeuties through its Barer Institute and investment in Rafael Pharmaceuticals, Inc. and other early-stage ventures, today announced several changes to its leadership team. William (Bill) Conkling will remain with the Company and assume the responsibilities of Chief Executive Officer from Ameet Mallik as of February 1, 2022. Bill Conkling has over 20 years of experience specializing in the development and commercialization of novel cancer therapeutics and currently serves as Rafael’s Chief Commercial and Business Officer.  Previously, Bill was Vice President Sales, Marketing, Market Access and Commercial Operations at Immunomedics where he built and led the US commercial...

Continue reading

OTC Markets Group Welcomes Mystic Holdings Inc. to OTCQX

NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Mystic Holdings Inc. (OTCQX: MSTH), a company focused on cannabis cultivation, production and retail, has qualified to trade on the OTCQX® Best Market. Mystic Holdings Inc. upgraded to OTCQX from the Pink® market. Mystic Holdings Inc. begins trading today on OTCQX under the symbol “MSTH.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.